|
Index of reports
> Cases resulting in disability (10)
> Cases with Rhabdomyolysis (6)
Below is the selection of adverse event reports related to Erythromycin that includes cases resulting in disability where reactions include rhabdomyolysis.
Adverse event in female receiving Erythromycin
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-29
Patient: female, weighing 150.0 kg (330.0 pounds)
Adverse reactions / side effects: Rhabdomyolysis, Skin Ulcer, Sepsis, Chronic Obstructive Pulmonary Disease, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Suspect drug(s):
Erythromycin
Administration route: Oral
Start date: 2006-03-25
End date: 2006-04-03
Zocor
Administration route: Oral
Other drugs received by patient: Amitriptyline Hydrochloride; Bumetanide; Dihydrocodeine; Lisinopril; Metformin; Rosiglitazone Maleate; Levothyroxine Sodium
Adverse event in 82 year old male receiving Erythromycin
Reported by a pharmacist from Norway on 2007-05-11
Patient: 82 year old male, weighing 102.0 kg (224.4 pounds)
Adverse reactions / side effects: Myalgia, Pneumonia Primary Atypical, Rhabdomyolysis, Drug Interaction, Orthostatic Hypotension, Myopathy
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Erythromycin
Start date: 2005-04-25
End date: 2005-05-06
Zocor
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2000-01-01
End date: 2005-05-22
Other drugs received by patient: Metoprolol; Amlodipine Besylate; Valsartan; Hydrochlorothiazide; Aspirin; Methotrexate; Furosemide
Adverse event in 82 year old male receiving Erythromycin
Reported by a pharmacist from Norway on 2007-05-08
Patient: 82 year old male, weighing 102.0 kg (224.4 pounds)
Adverse reactions / side effects: Myalgia, Pneumonia Primary Atypical, Rhabdomyolysis, Drug Interaction, Orthostatic Hypotension, Myopathy
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Erythromycin
Start date: 2005-04-25
End date: 2005-05-06
Zocor
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2000-01-01
End date: 2005-05-22
Other drugs received by patient: Metoprolol; Amlodipine Besylate; Valsartan; Hydrochlorothiazide; Aspirin; Methotrexate; Furosemide
Adverse event in 82 year old male receiving Erythromycin
Reported by a pharmacist from Norway on 2007-05-07
Patient: 82 year old male, weighing 102.0 kg (224.4 pounds)
Adverse reactions / side effects: Myalgia, Pneumonia Primary Atypical, Rhabdomyolysis, Drug Interaction, Orthostatic Hypotension, Myopathy
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Erythromycin
Start date: 2005-04-25
End date: 2005-05-06
Zocor
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2000-01-01
End date: 2005-05-22
Other drugs received by patient: Metoprolol; Amlodipine Besylate; Valsartan; Hydrochlorothiazide; Aspirin; Methotrexate; Furosemide
Adverse event in 83 year old male receiving Erythromycin
Reported by a pharmacist from Norway on 2007-04-13
Patient: 83 year old male, weighing 102.0 kg (224.4 pounds)
Adverse reactions / side effects: Pneumonia Primary Atypical, Rhabdomyolysis, Drug Interaction, Orthostatic Hypotension
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Erythromycin
Zocor
Administration route: Oral
Other drugs received by patient: Metoprolol; Amlodipine Besylate; Valsartan; Hydrochlorothiazide; Aspirin; Methotrexate; Furosemide
Adverse event in female receiving Erythromycin
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-01-24
Patient: female, weighing 150.0 kg (330.0 pounds)
Adverse reactions / side effects: Rhabdomyolysis, Skin Ulcer, Sepsis, Chronic Obstructive Pulmonary Disease, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Suspect drug(s):
Erythromycin
Administration route: Oral
Start date: 2006-03-25
Zocor
Administration route: Oral
Other drugs received by patient: Amitriptyline Hydrochloride; Bumetanide; Dihydrocodeine; Lisinopril; Metformin; Rosiglitazone Maleate; Levothyroxine Sodium
|
